Atlas Trials

A Study to Evaluate the Effects of Cenicriviroc Mesylate on Arterial Inflammation in People Living With HIV

Clinical trial NCT05630885 · COMPLETED

Trial details

NCT number
NCT05630885
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
HIV-1-infectionElevated Cardiovascular Risk
Start date
2023-05-30
Primary completion
2024-06-19
Enrollment
110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.